Sp0968 122 — Seattle, Washington

Sp0968 122 is a clinical research site located in Seattle, Washington, United States 98105.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Sp0968 122 has participated in 1 clinical trials.

Therapeutic areas: Electroencephalographic Neonatal Seizures, Epilepsy.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sp0968 122?

Sp0968 122 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sp0968 122 conducted?

Sp0968 122 has 1 clinical trials on record. Their work covers Electroencephalographic Neonatal Seizures, Epilepsy.

Is Sp0968 122 accredited by Crixeo Health?

Sp0968 122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sp0968 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.